Page last updated: 2024-10-31

apnea and Channelopathies

apnea has been researched along with Channelopathies in 1 studies

Apnea: A transient absence of spontaneous respiration.

Channelopathies: A variety of neuromuscular conditions resulting from MUTATIONS in ION CHANNELS manifesting as episodes of EPILEPSY; HEADACHE DISORDERS; and DYSKINESIAS.

Research Excerpts

ExcerptRelevanceReference
" In addition, pyridostigmine also resulted in resolution of apneas and improved respiratory status which suggests its potential therapeutic role in patients with PURA syndrome."4.12Hypotonic infant with PURA syndrome-related channelopathy successfully treated with pyridostigmine. ( Brooks, S; Crenshaw, M; DiBartolomeo, M; Geller, T; Iyadurai, S; Wyrebek, R, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wyrebek, R1
DiBartolomeo, M1
Brooks, S1
Geller, T1
Crenshaw, M1
Iyadurai, S1

Other Studies

1 other study available for apnea and Channelopathies

ArticleYear
Hypotonic infant with PURA syndrome-related channelopathy successfully treated with pyridostigmine.
    Neuromuscular disorders : NMD, 2022, Volume: 32, Issue:2

    Topics: Acetylcholinesterase; Apnea; Channelopathies; DNA-Binding Proteins; Epilepsy; Humans; Infant; Intell

2022